SCHEMBL24570892

SCHEMBL24570892

O=c1c2ccccc2n2c3ccc4c(c(=O)c5cccc6c(=O)c7ccccc7n4c65)c3c(=O)c3cccc1c32

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
P2RX4 Q99571 4/20 0.41
GLA P06280 3/20 0.40
DHFR P00374 1/20 0.38
ATM Q13315 1/20 0.37
PTPN1 P18031 1/20 0.36
HCRTR1 O43613 1/20 0.35
APEX1 P27695 1/20 0.35
SYK P43405 1/20 0.35
RECQL P46063 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NQO2 P16083 2/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24570753 0.91 HTT (0.41) HTTMAPTALDH1A1HPGDKDM4E
SCHEMBL23898662 0.90 ALDH1A1 (0.50) HTTMAPTALDH1A1HPGDKDM4E
SCHEMBL29636156 0.90 ALDH1A1 (0.50) HTTMAPTALDH1A1HPGDKDM4E
SCHEMBL29861263 0.86 ALDH1A1 (0.53) HTTMAPTALDH1A1HPGDKDM4E
SCHEMBL16389423 0.86 ALDH1A1 (0.53) HTTMAPTALDH1A1HPGDKDM4E
SCHEMBL24570969 0.85 MAPT (0.36) HTTMAPTALDH1A1HPGDKDM4E
SCHEMBL24570755 0.83 ALDH1A1 (0.44) HTTMAPTALDH1A1HPGDKDM4E
SCHEMBL24276354 0.82 ALDH1A1 (0.41) HTTMAPTALDH1A1HPGDKDM4E
SCHEMBL24570763 0.82 HTT (0.46) HTTMAPTALDH1A1HPGDKDM4E
SCHEMBL24570881 0.82 HTT (0.42) HTTMAPTALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204453-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204453-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP2E1, CYP1A2 HTT 1549/4885MAPT 2428/4885ALDH1A1 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.